about
Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malariaEffect of HIV-1 antiretroviral drugs on cytoadherence and phagocytic clearance of Plasmodium falciparum-parasitised erythrocytes.HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites.C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria.Safety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malariaCD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum.HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restrictionPyruvate kinase deficiency and malaria.The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria.PPARγ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria.CD36 and malaria: friends or foes?Approaches to studying costimulation of human antiviral T cell responses: prospects for immunotherapeutic vaccines.C5 deficiency and C5a or C5aR blockade protects against cerebral malariaLow Prolactin and High 20-α-Hydroxysteroid Dehydrogenase Levels Contribute to Lower Progesterone Levels in HIV-Infected Pregnant Women Exposed to Protease Inhibitor-Based Combination Antiretroviral Therapy.Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trialFunctional roles for C5a and C5aR but not C5L2 in the pathogenesis of human and experimental cerebral malaria.Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale.Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.Exploring the Factors Considered by People Living with HIV and Their Partners during Preconception.CD47-SIRPα Interactions Regulate Macrophage Uptake of Plasmodium falciparum-Infected Erythrocytes and Clearance of Malaria In Vivo.Murine Plasmodium chabaudi malaria increases mucosal immune activation and the expression of putative HIV susceptibility markers in the gut and genital mucosae.Disruption of JNK2 decreases the cytokine response to Plasmodium falciparum glycosylphosphatidylinositol in vitro and confers protection in a cerebral malaria model.Rosiglitazone modulates the innate immune response to Plasmodium falciparum infection and improves outcome in experimental cerebral malaria.Placental chondroitin sulfate A-binding malarial isolates evade innate phagocytic clearance.Mechanism of protection induced by vitamin A in falciparum malaria.An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection.CD36 deficiency induced by antiretroviral therapy.Peroxisome proliferator-activated receptor gamma and retinoid X receptor agonists have minimal effects on the interaction of endothelial cells with Plasmodium falciparum-infected erythrocytes.Chronic HIV infection impairs nonopsonic phagocytosis of malaria parasites.The importance of motherhood in HIV-positive women of reproductive age in Ontario, Canada.Nonopsonic phagocytosis of erythrocytes infected with ring-stage Plasmodium falciparum.Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages.CD36 mediates the phagocytosis of Plasmodium falciparum-infected erythrocytes by rodent macrophages.Estradiol Levels Are Altered in Human Immunodeficiency Virus-Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy.A phase I clinical study of inhaled nitric oxide in healthy adults.Perceived acceptability of progesterone to prevent preterm births and low birth weight among HIV-infected and HIV-uninfected Zambian pregnant women.Elevated Levels of Estradiol in Human Immunodeficiency Virus-Infected Pregnant Women on Protease Inhibitor-Based Regimens.Adjunctive therapy for severe malaria: a review and critical appraisal.Disruption of CD36 impairs cytokine response to Plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo.Cerebral malaria: human versus mouse studies.
P50
Q28742640-4FA94EFA-4C60-4B31-BD63-8D4CB95EC8F0Q30336129-303578AA-B1A8-4F75-AD7D-9E2EB1496771Q33286064-96445898-7A9F-42A7-8277-C38DBA6D54E9Q33420846-E27DE2E8-EEA0-45F3-9A0A-4D5466A79F5DQ33721892-05DFB985-9CC3-4882-93BC-9B90EF96C52EQ34521530-8E7E7300-6E3B-42EE-91E2-E68E915E33B6Q34687799-93B113D2-2B40-44DB-8C46-D665054D91FBQ34771070-FB8D4B78-3AC5-40B4-843C-1710D1D269FEQ35101529-1B0F7681-8B56-4C65-AA3E-8CC3BA0BF6FDQ35113069-3BF315DA-657B-437B-9ECF-AA80FCC20831Q35547450-773D768F-451B-4CAE-A6A7-E13AABA38F71Q36604795-AFDC742E-8625-429B-B135-49F20C638B3AQ36640015-725341C9-3979-4298-A19F-EDC336282738Q36816616-7AB62561-2B12-45D6-B026-76F27B4B4679Q37498149-6811E08D-FB7D-41C7-A137-E5F64DBC04ECQ37548166-948F47FD-3DF0-4CDC-A124-9F63583FBEC2Q38262285-DB43326E-4527-4B70-83B8-15F8AC7D65BAQ38379646-F29D58CA-39BC-4D2A-BEA0-70DE050B81E3Q38796194-DE2B394C-78E1-4010-BEAE-264A7D302134Q38885296-B7F7CD52-392B-48C6-9041-79F9F2B586DAQ38940970-49118E5A-BCFB-4EB2-A00B-19C574697B1CQ39192335-20684549-4785-4465-A599-BFD8CDDAEE6FQ39446904-D5AFC681-2841-4BDF-95F1-845A1D099A62Q39446910-12749BDA-A2FD-479F-9E1B-CAF9EF2B84D0Q39446916-98B1089D-2B70-4027-926F-2B77FB755197Q40410476-1B63B6FE-4BBD-468B-9DEA-D14B6B52A469Q40752137-1093464C-79DC-46E1-BF09-C9B97640765CQ40995222-4212FD0F-8251-405F-AC89-D569D25CFC46Q41653278-C169D497-EEBB-4B5B-A833-9571C4E37CC2Q42241438-1225F114-B445-493C-B401-98AE75624F50Q42258999-78FDD94A-B514-4C6A-A628-4D9F2113E5DEQ43612846-05C94113-69E8-4C02-B3F3-2D1D840C6F6AQ44727657-8C315D2D-8208-49B5-B30C-A548E2CF6BD6Q45324863-D6705C03-4244-4197-9B7F-9F81C5098572Q45922372-C0DB105E-D66F-4106-B380-E32E9C6F13CDQ46502334-EC0C0E04-64F9-41D5-ACD4-1C9AA4590D1DQ47616851-2948920E-920E-4B29-8D20-5D278AB93236Q47716363-B00901FE-9368-4633-B69F-034613F40872Q47826800-4932BD42-2CCE-4785-A6AC-59EF3D963721Q47938712-0EC26B59-9784-48AD-A6A0-4D4358C87649
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lena Serghides
@ast
Lena Serghides
@en
Lena Serghides
@es
Lena Serghides
@nl
Lena Serghides
@sl
type
label
Lena Serghides
@ast
Lena Serghides
@en
Lena Serghides
@es
Lena Serghides
@nl
Lena Serghides
@sl
prefLabel
Lena Serghides
@ast
Lena Serghides
@en
Lena Serghides
@es
Lena Serghides
@nl
Lena Serghides
@sl
P106
P21
P31
P496
0000-0002-2817-6134